SCHEMBL10069008

SCHEMBL10069008

O=C(NCCc1ccc(O)c(O)c1)OCCOCCOCCOCCO

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.55
HSD17B10 Q99714 3/20 0.55
KDM4E B2RXH2 3/20 0.55
ALDH1A1 P00352 3/20 0.55
HIF1A Q16665 2/20 0.55
LMNA P02545 2/20 0.55
HPGD P15428 2/20 0.55
BLM P54132 2/20 0.55
PTGS1 P23219 1/20 0.55
SLC7A5 Q01650 1/20 0.47
APP P05067 2/20 0.47
YWHAG P61981 1/20 0.47
GAA P10253 2/20 0.46
ALOX5 P09917 1/20 0.46
BACE1 P56817 1/20 0.46
TRPV1 Q8NER1 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ERCC1 P07992 1/20 0.46
ERCC4 Q92889 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10069007 0.86 MAPT (0.51) MAPTHSD17B10KDM4EALDH1A1HIF1A
SCHEMBL9976617 0.84 CA12 (0.41) MAPTALDH1A1LMNAMEN1KMT2A
SCHEMBL9976615 0.84 APP (0.54) MAPTHSD17B10KDM4EALDH1A1HIF1A
SCHEMBL9976606 0.83 MAPT (0.54) MAPTHSD17B10KDM4EALDH1A1HIF1A
SCHEMBL31542971 0.82 MAPT (0.56) MAPTHSD17B10KDM4EALDH1A1HIF1A
SCHEMBL4448682 0.81 MAPT (0.62) MAPTHSD17B10KDM4EALDH1A1HIF1A
SCHEMBL9976622 0.81 CA12 (0.59) MAPTALDH1A1GAAMEN1KMT2A
SCHEMBL28557038 0.80 MAPT (0.65) MAPTHSD17B10KDM4EALDH1A1HIF1A
SCHEMBL21388223 0.79 MAPT (0.59) MAPTHSD17B10KDM4EALDH1A1HIF1A
SCHEMBL7371177 0.77 TRPV1 (0.60) MAPTHSD17B10KDM4EALDH1A1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120157824-A1 MRI AND OPTICAL ASSAYS FOR PROTEASES NANOSCALE CORPORATION (US) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157824-A1 MRI AND OPTICAL ASSAYS FOR PROTEASES PREP, HPN, ADAM9 MAPT 905/4885HSD17B10 3050/4885KDM4E 4459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.